Register now for Fin24 Dashboard and get access to portfolios, watchlists, financial comparison tools, and a whole lot more to help you achieve your financial goals.

Data provided by McGregor BFA
All data is delayed
Loading...
Where am I? Home
 
Prices are delayed by 15min.
Join the Fin24.com conversation about JSE-listed stock by using every time you tweet.

Discovery staunches price bleed

Feb 19 2009 18:23 Ines Schumacher

Related Articles

Financial services smorgasbord

Growth stocks 'set to blossom'

Medical schemes ripe for buyouts

'Medical costs won't spiral'

 

Top Stories

Gauteng road project costs rocket

May 25 2012 13:58

The costs of the first phase of the Gauteng Freeway Improvement Project have increased significantly to almost R90bn, according to a report.

Sizeable drop in petrol price expected

May 24 2012 17:31

The Reserve Bank will maintain current interest rates, and a considerable reduction in the local petrol price is anticipated, says governor Gill Marcus.

JSE halts 'incorrect' trade

May 25 2012 11:36

The JSE has identified and stopped "incorrect" trades from one of its members, and will reverse the trades and lower the session's total value after the close.

 
Share Share line Print

Johannesburg - Medical insurance business Discovery Holdings staunched a nine-day share price decline on Thursday after issuing improved financial numbers - but uncertainty continues about the health of its offshore ventures.

Discovery gained as much as 6% intra-day and closed 4.5% higher on the JSE at 2 445c/share. This was after retreating from more than 2 600c/share on February 10 down to 2 380c/share, a value loss analysts said was related to apprehension ahead of its half-year figures ended December.

It was possible that investors were spooked after not receiving an alert from Discovery to inform them that earnings would be a fifth higher, an analyst said.

In terms of JSE reporting standards, public companies are required to inform shareholders of a 20% or more change in expected earnings levels.

Discovery Holdings reported a 19% increase in interim headline share earnings to R489m. Operating profit was about a fifth higher to R746m, after including its loss-making UK business units. Discovery Holdings declared an interim dividend of 25.5c/share.

In general terms, the company's healthcare business performed well but the global recession put pressure on Discovery's UK businesses and would continue to do so, analysts said.

"Investors have not fully bought into the offshore story," said Paul Theron, an analyst at Vestact. "Discovery has a good business but there's some anxiety about whether the UK business will prosper," he said.

PruProtect, Discovery's joint venture with the UK's Prudential Plc, posted a R104m loss in the six months to December. Discovery Holdings said this loss was in line with expectations, but Theron raised a flag over the business unit.

"Discovery faces more challenges in the UK. It will be targeting break-even but it's possible it'll come up short again," he said.

However, the flagship healthcare business, Discovery Health, would continue to perform well, said Wilhelm Hertzog, an analyst for Cape-based asset management firm Re:CM.

"Discovery has a unique product offering," said Hertzog. "This means it can afford to raise premiums because it has quite a sticky client base," he said. This was also true for Discovery's Life business, where profit margins were under pressure as it wrote more (lower margin) investments only business.

Discovery Holdings' income statement shows that claims increased 23% to R1.2bn. However, insurance premium revenue has increased by nearly 30% to R2.5bn from R2bn in the comparable period.

Most of this growth is driven by Discovery Life - it grew from R1 424m to R1 951m, an increase of R527m. This growth in premium revenue was driven by strong business growth and by inflation related increases," said Ricky Farber, CFO of Discovery Holdings.

"Over the past few days, Discovery shares were being sold because it didn't release a trading statement," said Hertzog. "That scared investors a bit."

The upward movement of the share price meant the market was now taking comfort in Discovery's good results, he said.

- Fin24.com

 
 
Comment on this story
0 comments
Comments have been closed for this article.
Facebook's intrinsic value
May 23 2012 11:32

When it comes to judging a company’s worth, value investors like Warren Buffett look at intrinsic value. By that measure, Facebook’s shares are worth less than $10. A Reuters analyst breaks down the math. (Reuters)

NicolaaSmith

CIPPA equals automatic zero erosion in the constant item economy We do not have stable – as in fixed real value – money. The real value of money is generally accepted by the public at large to be stable – as in fixed – in low inflation economies, but this is not true. The be... Read their blog...

Recently updated
Podcasts
The Sishen saga

Legal expert Peter Leon on the increasingly complex legal wrangle over the Sishen Iron Ore mine. Time: 8:17 Listen Here...

Before you list

Is the clarion call of the JSE calling? Listen to Fin24’s expert panel discussion before you list your small business. Time: 17:29

Compare and Buy

Compare and apply for hundreds of financial products from many suppliers.

Credit cards Medical aid Current accounts Think Money

Money Clinic

Money Clinic Do you have a question about your finances? We'll get an expert opinion.
Click here...

Loading...